Carla Rios Luci-rekin lankidetzan egindako argitalpenak (3)

2020

  1. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells

    Investigational New Drugs, Vol. 38, Núm. 3, pp. 584-598

2017

  1. DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells

    European Journal of Pharmaceutical Sciences, Vol. 105, pp. 159-168

2013

  1. Molecular docking studies of the interaction between propargylic enol ethers and human DNA topoisomerase IIα

    Bioorganic and Medicinal Chemistry Letters, Vol. 23, Núm. 19, pp. 5382-5384